Short Talk: Adaptive Immune Resistance Emerges From Tumor-Initiating Stem Cells iconShort Talk: Adaptive Immune Resistance Emerges From Tumor-Initiating Stem Cells

Short Talk: Adaptive Immune Resistance Emerges From Tumor-Initiating Stem Cells

Aug 17, 2020 6:15pm ‐ Aug 17, 2020 6:30pm
Short Talk: Characterization of Myeloid Cells Subsets in the Tumor Microenvironment of Merkel Cell Carcinoma iconShort Talk: Characterization of Myeloid Cells Subsets in the Tumor Microenvironment of Merkel Cell Carcinoma

Short Talk: Characterization of Myeloid Cells Subsets in the Tumor Microenvironment of Merkel Cell Carcinoma

Aug 17, 2020 6:30pm ‐ Aug 17, 2020 6:45pm
Short Talk: ADT-Mediated Intra-Tumoral Myeloid Infiltration Promotes Resistance to Immune Checkpoint Blockade in Prostate Cancer iconShort Talk: ADT-Mediated Intra-Tumoral Myeloid Infiltration Promotes Resistance to Immune Checkpoint Blockade in Prostate Cancer

Short Talk: ADT-Mediated Intra-Tumoral Myeloid Infiltration Promotes Resistance to Immune Checkpoint Blockade in Prostate Cancer

Aug 17, 2020 6:45pm ‐ Aug 17, 2020 7:00pm
[Full Session] Therapeutic Play I icon[Full Session] Therapeutic Play I

[Full Session] Therapeutic Play I

Aug 18, 2020 9:00am ‐ Aug 18, 2020 10:40am
Engineering Next-Generation CAR-T Cell Therapy for Cancer iconEngineering Next-Generation CAR-T Cell Therapy for Cancer

Engineering Next-Generation CAR-T Cell Therapy for Cancer

Aug 18, 2020 9:05am ‐ Aug 18, 2020 9:30am
Clinical Applications of Adenosine Pathway Inhibitors iconClinical Applications of Adenosine Pathway Inhibitors

Clinical Applications of Adenosine Pathway Inhibitors

Aug 18, 2020 9:30am ‐ Aug 18, 2020 9:55am
Short Talk: Cell Penetrating Peptides Improve T Cell Response to Neoantigen Peptide Vaccines iconShort Talk: Cell Penetrating Peptides Improve T Cell Response to Neoantigen Peptide Vaccines

Short Talk: Cell Penetrating Peptides Improve T Cell Response to Neoantigen Peptide Vaccines

Aug 18, 2020 9:55am ‐ Aug 18, 2020 10:10am
Short Talk: Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumours iconShort Talk: Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumours

Short Talk: Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumours

Aug 18, 2020 10:10am ‐ Aug 18, 2020 10:25am
Short Talk: Engineering Remotely Controllable CAR T Cells for Cancer Immunotherapy iconShort Talk: Engineering Remotely Controllable CAR T Cells for Cancer Immunotherapy

Short Talk: Engineering Remotely Controllable CAR T Cells for Cancer Immunotherapy

Aug 18, 2020 10:25am ‐ Aug 18, 2020 10:40am
Engineered Nanobiomaterials for Cancer Immunotherapy iconEngineered Nanobiomaterials for Cancer Immunotherapy

Engineered Nanobiomaterials for Cancer Immunotherapy

Aug 18, 2020 10:40am ‐ Aug 18, 2020 11:05am